By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoVent 



      China
Phone: n/a Fax: n/a


SEARCH JOBS

OncoVent Co., Ltd. is a China-based pharmaceutical company specializing in the development of combination immunotherapy for the Greater China market with registered funds of $9.26 million. OncoVent is focused on the development, manufacturing and commercialization of anti-MUC1 MAb AR20.5 as a Cancer Immunotherapy Product within China with pancreatic cancer as its first target.

LEADERSHIP:

Founder and CEO: Eric Shi


Key Statistics


Email:
Ownership: Private

Web Site: OncoVent
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->